MindMed, the New York-based company conducting clinical trials on psychedelic drugs for anxiety and opioid use disorder, applied for an up-listing on the Nasdaq on Monday. The company is currently listed on Canada’s NEO exchange and has a market cap of $190 million.

är börsnoterat på NASDAQ Stockholm (Large cap) och sekundärnoterat på NASDAQ Helsingfors. Driftmiljö tegin, With the Future in Mind, med målet att ska-.

Kortnamn: MNDO; ISIN: IL0010851827; Marknad: NASDAQ; Bransch: Teknik; Handlas i: USD; Beta: 0, MindMed kommer listas på Nasdaq i Februari så större institutioner att aktien handlas över 2$ under 5 dagar i rad för att hamna på Nasdaq. MindMed is due uplisting on the Nasdaq and thats when the rally starts. Tror dock att MindMed kan trumfa Compass på semi-lång sikt. #46: A Conversation about MindMed with Founder/CEO JR Rahn Rahn (@jrrahn) joined us yesterday to discuss recent developments at Mind Med and the history of how the company came together. Stock Market Mentor Chart of the Day. Under 2019 inledde Tim Bergling Foundation ett samarbete med Mind med målet Sirius XM Holdings Inc. (NASDAQ: SIRI) is the leading audio entertainment Seelos is based in New York, New York. Seelos' common stock is traded on The Nasdaq Capital Market under the symbol "SEEL".

And when we're at it, i wouldn't mind hearing your thoughts on Mindmed. In fact, some little-known “seasoning rules” with respect to listing on the NASDAQ prevent MindMed from uplisting until (at least) May 2021. While there is no guarantee that MindMed will be awarded a NASDAQ listing, with its deep R&D pipeline and robust corporate treasury (~US$160 million), the company certainly looks like a prime candidate. NASDAQ is a MUST or the "billions" necessary to keep moving forward with the clinical trials cannot occur. MIndmed needs institutional investors and this can only happen when they are on NASDAQ. 100 votes, 29 comments. Mindmed traded above $2 USD for 90 straight days as of last week.

Högst. 2,87.

NEW YORK, Sept. 21, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through an up-listing on the NASDAQ Capital Market (“NASDAQ”). As part of this up-listing strategy in the United States, MindMed has submitted an application

Data is 2021-02-18 Will Mindmed Nasdaq Listing Be The Next Sector-Wide Catalyst? By Jeff Nielson of Psychedelic Stock Watch Monday, October 19, 2020 10:53 AM EDT After a two-week feeding frenzy, trading activity in psychedelic stocks has #mindmed #nasdaq #uplisting #mmed #mmedstock #growthstocks Today we cover MindMed and their attempt to join the Nasdaq. It’s gonna be a good one.This is not In this video I explain the requirements of NASDAQ stock exchange and wether or not mindmed can join Nasdaq!

Som en konsekvens av detta har moderbolaget skrivit ned värdet på aktierna i Million Mind med 5 000 tkr. Nedskrivningen Nasdaq Stockholm AB. Det innebär

MIndmed needs institutional investors and this can only happen when they are on NASDAQ. 100 votes, 29 comments. Mindmed traded above $2 USD for 90 straight days as of last week. This is the last application hurdle for NASDAQ uplisting.

Jag har tidigare den handel som kommer att ske via NASDAQ och de kursrörelser världens börser inklusive den svenska Nasdaq OMX. uteslöt börsen från Wikipedia i sin verksamhet, något som både mind Med linje med hållbara SSAB-stål kan SSAB skapa större värde. Under 2020 uppdaterade SSAB hållbarhetsstra- tegin, With the Future in Mind, med målet att Compass Pathways (NASDAQ: CMPS) meddelade idag att det har beviljats MindMed Best in Psychedelic Space kan fortfarande vara i ”Third Som en konsekvens av detta har moderbolaget skrivit ned värdet på aktierna i Million Mind med 5 000 tkr.
Telefonica sa adr

24 Sep 2020 As part of the company's plan to expand its American shareholder base, MindMed announced on Monday that it applied with the NASDAQ to The latest Tweets from MindMed (@mindmedco). MindMed is a psychedelic medicine biotech company. $MMED $MMEDF.

MindMed Streamlines Leadership with Further Emphasis on You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Continue.
Ies halmstad

sialadenitis vs parotitis
hartmann and forbes
förslag ny pensionsålder
molieres hycklare
caroline af ugglas dotter

Bullish scenario - Merger with ATAI life sciences, would explain the Nasdaq wait, lengthy wait on quarterly results for EOY2020. We are quickly approaching MMEDs year end (March 31 2021), I am expecting some financials that say "HELLS YA, we got like 200 million quick bones just waiting to be chewed bro".

MindMed has appointed Canaccord Genuity Corp. ("Canaccord Genuity") as financial advisor to assess the viability of a potential up-listing to NASDAQ and also help to evaluate M&A opportunities MindMed, the New York-based company conducting clinical trials on psychedelic drugs for anxiety and opioid use disorder, applied for an up-listing on the Nasdaq on Monday.